Standard BioTools Basic Shares Outstanding 2010-2025 | LAB
Standard BioTools basic shares outstanding from 2010 to 2025. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
| Standard BioTools Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $353 |
| 2023 | $79 |
| 2022 | $78 |
| 2021 | $76 |
| 2020 | $72 |
| 2019 | $67 |
| 2018 | $40 |
| 2017 | $33 |
| 2016 | $29 |
| 2015 | $29 |
| 2014 | $28 |
| 2013 | $25 |
| 2012 | $22 |
| 2011 | $18 |
| 2010 | $2 |
| 2009 | $2 |
| Standard BioTools Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2025-03-31 | $378 |
| 2024-12-31 | $353 |
| 2024-09-30 | $372 |
| 2024-06-30 | $372 |
| 2024-03-31 | $294 |
| 2023-12-31 | $79 |
| 2023-09-30 | $79 |
| 2023-06-30 | $79 |
| 2023-03-31 | $79 |
| 2022-12-31 | $78 |
| 2022-09-30 | $79 |
| 2022-06-30 | $78 |
| 2022-03-31 | $77 |
| 2021-12-31 | $76 |
| 2021-09-30 | $76 |
| 2021-06-30 | $75 |
| 2021-03-31 | $75 |
| 2020-12-31 | $72 |
| 2020-09-30 | $72 |
| 2020-06-30 | $71 |
| 2020-03-31 | $70 |
| 2019-12-31 | $67 |
| 2019-09-30 | $69 |
| 2019-06-30 | $69 |
| 2019-03-31 | $58 |
| 2018-12-31 | $40 |
| 2018-09-30 | $39 |
| 2018-06-30 | $39 |
| 2018-03-31 | $39 |
| 2017-12-31 | $33 |
| 2017-09-30 | $35 |
| 2017-06-30 | $29 |
| 2017-03-31 | $29 |
| 2016-12-31 | $29 |
| 2016-09-30 | $29 |
| 2016-06-30 | $29 |
| 2016-03-31 | $29 |
| 2015-12-31 | $29 |
| 2015-09-30 | $29 |
| 2015-06-30 | $29 |
| 2015-03-31 | $28 |
| 2014-12-31 | $28 |
| 2014-09-30 | $28 |
| 2014-06-30 | $28 |
| 2014-03-31 | $27 |
| 2013-12-31 | $25 |
| 2013-09-30 | $26 |
| 2013-06-30 | $25 |
| 2013-03-31 | $25 |
| 2012-12-31 | $22 |
| 2012-09-30 | $23 |
| 2012-06-30 | $21 |
| 2012-03-31 | $20 |
| 2011-12-31 | $18 |
| 2011-09-30 | $20 |
| 2011-06-30 | $20 |
| 2011-03-31 | $11 |
| 2010-12-31 | $2 |
| 2010-09-30 | $2 |
| 2010-06-30 | $2 |
| 2010-03-31 | $2 |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.456B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.059B | 59.87 |
| Doximity (DOCS) | United States | $11.521B | 53.34 |
| Hims & Hers Health (HIMS) | United States | $11.158B | 115.93 |
| Tempus AI (TEM) | United States | $11.000B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.915B | 0.00 |
| Hinge Health (HNGE) | United States | $4.037B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.827B | 59.80 |
| Privia Health (PRVA) | United States | $2.804B | 191.67 |
| Enovis (ENOV) | United States | $1.791B | 9.99 |
| Phreesia (PHR) | United States | $1.693B | 0.00 |
| Schrodinger (SDGR) | United States | $1.476B | 0.00 |
| 10x Genomics (TXG) | United States | $1.426B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.420B | 0.00 |
| Azenta (AZTA) | United States | $1.409B | 65.49 |
| Omnicell (OMCL) | United States | $1.377B | 24.30 |
| Evolent Health (EVH) | United States | $1.322B | 112.60 |
| Claritev (CTEV) | United States | $0.742B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.605B | 0.00 |
| Veradigm (MDRX) | United States | $0.509B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.495B | 0.00 |
| Talkspace (TALK) | United States | $0.465B | 139.00 |
| TruBridge (TBRG) | United States | $0.352B | 780.67 |
| Outset Medical (OM) | United States | $0.340B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.262B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.255B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.207B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.165B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.133B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.105B | 0.00 |
| Pulmonx (LUNG) | United States | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.086B | 0.00 |
| 111 (YI) | China | $0.062B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.049B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |